Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study

Autor: Van Cutsem, E. ^*, Boni, C., Tabernero, J., Massuti, B., Middleton, G., Dane, F., Reichardt, P., Pimentel, F.L., Cohn, A., Follana, P., Clemens, M., Zaniboni, A., Moiseyenko, V., Harrison, M., Richards, D.A., Prenen, H., Pernot, S., Ecstein-Fraisse, E., Hitier, S., Rougier, P.

Publikováno v: In Annals of Oncology January 2015 26(1):149-156

Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials

Autor: Bottomley, A., Pe, M., Sloan, J., Basch, E., Bonnetain, F., Calvert, M., Campbell, A., Cleeland, C., Cocks, K., Collette, L., Dueck, A.C., Devlin, N., Flechtner, H.H., Gotay, C., Greimel, E., Griebsch, I., Groenvold, M., Hamel, J.F., King, M., Kluetz, P.G., Koller, M., Malone, D.C., Martinelli, F., Mitchell, S.A., Moinpour, C.M., Musoro, J.Z., O'Connor, D., Oliver, K., Piault-Louis, E., Piccart, M., Pimentel, F.L., Quinten, C., Reijneveld, J.C., Schurmann, C., Smith, A.W., Soltys, K.M., Sridhara, R., Taphoorn, M.J.B., Velikova, G., Coens, C., Setting Int Stand Analyzing

Publikováno v: Clinical trials, 15(6), 624-630. SAGE Publications Ltd
Clinical Trials, 15(6), 624-630
Bottomley, A, Pe, M, Sloan, J, Basch, E, Bonnetain, F, Calvert, M, Campbell, A, Cleeland, C, Cocks, K, Collette, L, Dueck, A C, Devlin, N, Flechtner, H-H, Gotay, C, Greimel, E, Griebsch, I, Groenvold, M, Hamel, J-F, King, M, Kluetz, P G, Koller, M, Malone, D C, Martinelli, F, Mitchell, S A, Moinpour, C M, Musoro, J Z, O’Connor, D, Oliver, K, Piault-Louis, E, Piccart, M, Pimentel, F L, Quinten, C, Reijneveld, J C, Schürmann, C, Smith, A W, Soltys, K M, Sridhara, R, Taphoorn, M J B, Velikova, G & Coens, C 2018, ' Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials ', Clinical trials, vol. 15, no. 6, pp. 624-630 . https://doi.org/10.1177/1740774518795637

Background There is currently a lack of consensus on how health-related quality of life and other patient-reported outcome measures in cancer randomized clinical trials are analyzed and interpreted. This makes it difficult to compare results across r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee01e843c7e657b7ecec9ba07464cc03
https://doi.org/10.1177/1740774518795637

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards

Autor: Bottomley, A., Pe, M., Sloan, J., Basch, E., Bonnetain, F., Calvert, M., Campbell, A., Cleeland, C., Cocks, K., Collette, L., Dueck, A.C., Devlin, N., Flechtner, H.H., Gotay, C., Greimel, E., Griebsch, I., Groenvold, M., Hamel, J.F., King, M., Kluetz, P.G., Koller, M., Malone, D.C., Martinelli, F., Mitchell, S.A., Moinpour, C.M., Musoro, J., O'Connor, D., Oliver, K., Piault-Louis, E., Piccart, M., Pimentel, F.L., Quinten, C., Reijneveld, J.C., Schurmann, C., Smith, A.W., Soltys, K.M., Taphoorn, M.J.B., Velikova, G., Coens, C., Setting Int Stand Analyzing

Publikováno v: Lancet Oncology, 17(11), E510-E514. Lancet Publishing Group
The Lancet Oncology, 17(11), E510-E514
Bottomley, A, Pe, M, Sloan, J, Basch, E, Bonnetain, F, Calvert, M, Campbell, A, Cleeland, C, Cocks, K, Collette, L, Dueck, A C, Devlin, N, Flechtner, H-H, Gotay, C, Greimel, E, Griebsch, I, Groenvold, M, Hamel, J-F, King, M, Kluetz, P G, Koller, M, Malone, D C, Martinelli, F, Mitchell, S A, Moinpour, C M, Musoro, J, O'Connor, D, Oliver, K, Piault-Louis, E, Piccart, M, Pimentel, F L, Quinten, C, Reijneveld, J C, Schürmann, C, Smith, A W, Soltys, K M, Taphoorn, M J B, Velikova, G, Coens, C & Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data (SISAQOL) consortium 2016, ' Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials : a start in setting international standards ', Lancet Oncology, vol. 17, no. 11, pp. E510-E514 . https://doi.org/10.1016/S1470-2045(16)30510-1

Measures of health-related quality of life (HRQOL) and other patient-reported outcomes generate important data in cancer randomised trials to assist in assessing the risks and benefits of cancer therapies and fostering patient-centred cancer care. Ho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79dda2b58967c2b2dfb04a6e26c4219d
https://research.vumc.nl/en/publications/2e2a98a0-765a-4d1e-95ef-a41514b90ccd

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.